AORT · Artivion, Inc. · Webcasts, Transcripts & Audio
$19.10
-0.30 (-1.55%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$931.88M
Shares
48.79M
Volume · Nov 13
558.04K
Avg daily vol (3M)
672.56K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Artivion, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Artivion, Inc. (AORT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-10
Artivion, Inc. (AORT) November 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-05
Artivion, Inc. (AORT) Q3 2026 Earnings Call Transcript
Positive tone
AMDS adoption barriers
Nexus U.S. launch
Onyx growth and manufacturing capacity
Revenue
$123.79M
▲ 9.2% YoY Diluted EPS
$-0.16
▼ 223.1% YoY Gross margin
61.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-08-12
Artivion, Inc. (AORT) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Artivion, Inc. (AORT) Q2 2026 Earnings Call Transcript
Revenue
$125.76M
▲ 11.3% YoY Diluted EPS
$-0.28
▼ 1033.3% YoY Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
Artivion, Inc. (AORT) June 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Artivion, Inc. (AORT) Q1 2026 Earnings Call
Positive tone
AMDS commercialization
Endospan/Nexus acquisition
Pipeline and clinical trials
Revenue
$116.34M
▲ 17.5% YoY Diluted EPS
$0.03
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript
Confident tone
Stent Grafts / AMDS
On-X Mechanical Valve
NEXUS / EndoSpan Partnership
Revenue
$115.99M*
▲ 19.2% YoY Gross margin
63.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript
Confident tone
AMDS Stent Graft Growth and U.S. Launch
Pipeline and Future Launches (NEXUS, Arcevo, CVO)
On-X Mechanical Valve Momentum
Revenue
$113.39M
▲ 18.4% YoY Diluted EPS
$0.13
Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript
Confident tone
AMDS U.S. launch following HDE approval
On-X mechanical heart valve growth
Stent graft portfolio and pipeline expansion
Revenue
$112.97M
▲ 15.3% YoY Diluted EPS
$0.03
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript
Confident tone
AMDS U.S. launch
Cybersecurity recovery and tissue backlog
On-X mechanical valve growth
Revenue
$98.98M
▲ 1.6% YoY Diluted EPS
$-0.01
▼ 105.6% YoY Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript
Confident tone
AMDS HDE approval and launch
Stent graft portfolio
Capital structure and Endospan option
Revenue
$97.31M*
▲ 3.9% YoY Gross margin
63.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript
Confident tone
Product portfolio results
Revenue growth and financial performance
AMDS regulatory progress
Revenue
$95.78M
▲ 9% YoY Diluted EPS
$-0.05
Gross margin
63.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript
Confident tone
Leverage and margin expansion outlook
Endospan/NEXUS partnership update
Stent graft portfolio performance
Revenue
$98.02M
▲ 9.8% YoY Diluted EPS
$-0.05
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript
Confident tone
On-X Aortic Valve
International Expansion
AMDS / PERSEVERE Trial
Revenue
$97.43M
▲ 17.1% YoY Diluted EPS
$0.18
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript
Confident tone
Clinical trial results
Product revenue growth
Profitability and cash flow
Revenue
$93.67M*
▲ 18% YoY Gross margin
65.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript
Revenue
$87.85M
▲ 14.3% YoY Diluted EPS
$-0.24
Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript
Revenue
$89.25M
▲ 11.1% YoY Diluted EPS
$-0.08
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript
Revenue
$83.23M
▲ 7.8% YoY Diluted EPS
$-0.33
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Artivion, Inc. (AORT) Q4 2022 Earnings Call Transcript
Revenue
$79.40M*
▲ 0% YoY Gross margin
64.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Artivion, Inc. (AORT) Q3 2022 Earnings Call Transcript
Revenue
$76.84M
▲ 6.4% YoY Diluted EPS
$-0.34
▼ 230.8% YoY Gross margin
63.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Artivion, Inc. (AORT) Q2 2022 Earnings Call Transcript
Revenue
$80.34M
▲ 5.5% YoY Diluted EPS
$-0.11
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Artivion, Inc. (AORT) Q1 2022 Earnings Call Transcript
Revenue
$77.21M
▲ 8.6% YoY Diluted EPS
$-0.08
Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Artivion, Inc. (AORT) Q4 2021 Earnings Call Transcript
Revenue
$79.39M*
▲ 16.9% YoY Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Artivion, Inc. (AORT) Q3 2021 Earnings Call Transcript
Revenue
$72.21M
▲ 10.9% YoY Diluted EPS
$0.26
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Artivion, Inc. (AORT) Q2 2021 Earnings Call Transcript
Revenue
$76.15M
▲ 41.6% YoY Diluted EPS
$-0.06
Gross margin
66.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Artivion, Inc. (AORT) Q1 2021 Earnings Call Transcript
Revenue
$71.09M
▲ 7% YoY Diluted EPS
$-0.08
Gross margin
67.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Artivion, Inc. (AORT) Q4 2020 Earnings Call Transcript
Revenue
$67.90M*
▼ 2.6% YoY Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Artivion, Inc. (AORT) Q3 2020 Earnings Call Transcript
Revenue
$65.13M
▼ 4.1% YoY Diluted EPS
$-0.08
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-02
Artivion, Inc. (AORT) Q2 2020 Earnings Call Transcript
Revenue
$53.77M
▼ 24.4% YoY Diluted EPS
$-0.10
▼ 242.9% YoY Gross margin
66.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-01
Artivion, Inc. (AORT) Q1 2020 Earnings Call Transcript
Revenue
$66.43M
▼ 1.6% YoY Diluted EPS
$-0.18
Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Artivion, Inc. (AORT) Q4 2019 Earnings Call
Revenue
$69.70M
▲ 2.8% YoY Diluted EPS
$-0.02
Gross margin
66.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–31 of 31 webcasts
Key facts
CIK
784199
CUSIP
228903100
13F (30d)
170 filings
155 filers
Visit website
Investor relations